Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 10896 filtered startups

Grale

Grale is a GreenTech company from Sweden with the vision to end plastic pollution catastrophe. Conventional plastics are made from petroleum and stay in the environment up to 1000 years! By 2050, the oceans could have more plastic than fish. We are on a mission to change that! 🏆 Grale has been awarded as the “World’s Most Innovative Sustainability Startup” among 1400 companies Worldwide! đŸ„‡Â  We were also recently received the prestigious “Global Tech Innovator" award among 2000 technology companies worldwide. We are now scaling our team in order to continue our mission of creating a world free from plastic pollution, where circularity has been enabled.  Please see our job openings and connect with us here: https://career.grale.com

SimpleSign

SimpleSign Àr ett lönsamt och organiskt snabbvÀxande SaaS-bolag. Vi erbjuder en helhetslösning för digitala avtal och elektroniska signaturer. Sedan starten har fler Àn 10 miljoner e-signerade dokument signerats med vÄr lösning. Vi arbetar internationellt med kunder i 20+ lÀnder. Vill du vara en bidragande person till vÄr expansion fylld med utmaningar, idéer och kreativitet? IsÄfall ska du söka jobb hos oss!

athme

athme is building a category defining app for real world sports and social connection. Our platform makes it easy to discover activities, join games, and build communities through movement. From football, padel, badminton, volleyball, basketball, table tennis, running, fitness, and chess to handball, bouldering, and pickleball, athme helps people find the right activity and the right people to play with. We believe sport is one of the strongest drivers of health, belonging, and community. But for many people, getting active is still harder than it should be. Finding players, organizing games, and joining activities often takes too much effort. athme is built to remove that friction and make sport a more natural part of everyday life. Our mission is to help more people move, meet, and build real connections through sport. We are creating a product with the potential to become a core platform for active communities, starting locally and built to scale.

Gullis Drinks

Gullis is a sparkling soft drink based on 100% natural juice. We strive to keep as many vitamins and fibers in our drink by using fresh fruit and no added sugars. A note from the founder: I grew up in a small village near the city with a modest orchard where fresh juices were made from various fruits. Back then, a bottle of pear juice or a fresh pear or apple was a real treat. As we grew older and started school in the city, we encountered sodas full of additives. Nowadays, fruit juices are often replaced by trendy brands with sugar substitutes, added vitamins, and energy drinks. While fruit juices are no longer seen as 'hip' or 'cool,' I want to change that. My goal is to give natural, sugar-free juices a modern and appealing image because all the vitamins, minerals, and proteins are already in nature— you just need to know how to present them properly.

Shipshark

Shipshark er et moderne lagerhotel i Randers. Vi hĂ„ndterer pluk & pak af webshop ordrer for +60 webshops – fra smĂ„ start-ups til veletablerede brands. Vores hverdag er prĂŠget af tempo, samarbejde og et stĂŠrkt fokus pĂ„ struktur, kvalitet og lĂžbende optimering. Vi lĂŠgger vĂŠgt pĂ„ at vi har det sjovt i det daglige samtidig med at vi er effektive og arbejdsomme. Bliv en del af en ung moderne virksomhed i vĂŠkst med masser af udviklingsmuligheder.

Landjord ApS

Landjord converts farmland into wild nature and private camping sites. We solve the lack of authentic, quiet nature experiences with comfort, while creating new income for farmers. Campers get access to secluded, well-designed spots, and their stay supports biodiversity and green transition. It’s a scalable model combining tourism, nature restoration and agriculture.

Fortifai

Fortifai simplifies compliance by turning complex regulatory requirements into structured, actionable data. Founded in Oslo and backed by leading VCs, Fortifai combines deep domain expertise with modern data infrastructure to transform compliance from a reactive reporting burden into a proactive, continuous process.

Customers 1st

Customers 1st er en moderne softwarevirksomhed, der udvikler en avanceret retailplatform, som allerede bruges af tusindvis af butikker. Vi leverer banebrydende teknologi, der hjĂŠlper butikker med at optimere deres forretning, skabe bedre kundeoplevelser og skalere til nye hĂžjder. Som en ung virksomhed i vĂŠkst har vi store ambitioner og en kultur, hvor innovation, udvikling og samarbejde er i fokus. Vi arbejder med de nyeste teknologier og tilbyder spĂŠndende karrieremuligheder for dem, der vil vĂŠre med til at forme fremtidens retail. Vores team i Odense er dynamisk, passioneret og ikke mindst fyldt med god energi – vi tror pĂ„, at et sjovt arbejdsmiljĂž er nĂžglen til succes. Vil du vĂŠre en del af rejsen?

Scalero

Scalero offers end-to-end lifecycle marketing support—from implementations and data engineering to campaign execution and automation. They handle the technical heavy lifting and the creative details: data, design, copy, strategy, and deliverability. Whether you need a hands-on execution team or strategic advisors, Scalero integrates into your team to meet your goals. Learn more at scalero.io

Emigreat

At Emigreat, we are building a digital infrastructure that streamlines relocation processes for international employees. HR and global mobility managers can use our web app to connect with employees, assess their immigration status, automate applications, and manage deadlines and documents. What used to take months, now takes less than a week and a few clicks of a button. Emigreat enables better legal compliance and decision-making for companies, peace of mind for employees, and time saved for relocation agencies.

Airlabs

Airlabs is an organisation with foundations in atmospheric chemistry and airflow engineering that has been established out of a desire to tackle the huge social problem of air quality in cities across the world. Our work is the result of active collaboration between our team and some of the world’s leading applied environmental research and engineering institutes. Our team brings together experts from widely varying disciplines: from atmospheric chemistry to pollution monitoring, from fluid dynamics to environmental health and from economics to engineering and design.

F I X A T E

At F I X A T E, we empower companies with the knowledge, advice, and complete deliveries needed to redefine user support. From strategic guidance to practical solutions, we help organisations provide premium services that exceed expectations. Our team is more than just support providers - we’re about building real, meaningful relationships. Working as one, we celebrate success, face challenges, and constantly adapt to deliver better. We believe that mistakes are opportunities, accountability is key, and speaking up leads to growth.

CYVI

CYVI is an early-stage cyber insurance platform backed by one of Europe’s top VCs. With less than 5% of European small and medium-sized enterprises (SMEs) protected by cyber insurance, CYVI is on a mission to reinvent cyber insurance. CYVI enables multiple B2B channels to sell cyber insurance while helping insurers monitor client security hygiene. Our compliance cybersecurity platform allows channels such as IT providers to provide embedded cyber insurance to their clients and create new revenue streams in the process.

NODES

NODES is the independent marketplace for a sustainable energy future where grid owners, producers, and consumers of energy can trade decentralized flexibility and energy. NODES, as an independent market operator, is addressing key trends and challenges in the energy system such as increased share of renewable power production, decentralized generation, and the rapid change of customer behavior. NODES vision is to build Europe’s most customer-centric, integrated energy marketplace to unlock the value of local flexible power resources and support the drive to a sustainable, emission-free future. NODES mission is to facilitate the optimal use of flexibility in the grid by offering an open, integrated marketplace to all flexibility providers and grid operators.

Pharmasum Therapeutics AS

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.